These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 500500
1. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties. Oki T, Kitamura I, Yoshimoto A, Matsuzawa Y, Shibamoto N, Ogasawara T, Inui T, Takamatsu A, Takeuchi T, Masuda T, Hamada M, Suda H, Ishizuka M, Sawa T, Umezawa H. J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500 [Abstract] [Full Text] [Related]
2. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone. Oki T, Yoshimoto A, Matsuzawa Y, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952 [Abstract] [Full Text] [Related]
3. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity. Matsuzawa Y, Yoshimoto A, Oki T, Naganawa H, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953 [Abstract] [Full Text] [Related]
4. New anthracyclinone metabolites from two blocked mutants of Streptomyces galilaeus MA144-M1. Tobe H, Yoshimoto A, Ishikura T, Naganawa H, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1982 Dec; 35(12):1641-5. PubMed ID: 6962794 [Abstract] [Full Text] [Related]
5. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants. Yoshimoto A, Matsuzawa Y, Oki T, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976 [Abstract] [Full Text] [Related]
6. 13-Deoxycarminomycin, a new biosynthetic anthracycline. Cassinelli G, Forenza S, Rivola G, Arcamone F, Grein A, Merli S, Casazza AM. J Nat Prod; 1985 Aug; 48(3):435-9. PubMed ID: 3861771 [Abstract] [Full Text] [Related]
7. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides. Matsuzawa Y, Yoshimoto A, Shibamoto N, Tobe H, Oki T, Naganawa H, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928 [Abstract] [Full Text] [Related]
8. [Aclacinomycin A: a new antitumor antibiotic]. Egorov LV, Ivanitskaia LP, Navashin SM. Antibiotiki; 1982 Aug; 27(7):540-55. PubMed ID: 6753735 [No Abstract] [Full Text] [Related]
9. Griseorubins, a new family of antibiotics with antimicrobial and antitumor activity. I. Taxonomy of the producing strain, fermentation, isolation and chemical characterization. Dornberger K, Berger U, Knöll H. J Antibiot (Tokyo); 1980 Jan; 33(1):1-8. PubMed ID: 7372542 [Abstract] [Full Text] [Related]
10. Arugomycin, a new anthracycline antibiotic. I. Taxonomy, fermentation, isolation and physico-chemical properties. Kawai H, Hayakawa Y, Nakagawa M, Furihata K, Furihata K, Shimazu A, Seto H, Otake N. J Antibiot (Tokyo); 1987 Sep; 40(9):1266-72. PubMed ID: 3479412 [Abstract] [Full Text] [Related]
12. New anthracycline antibiotics. Oki T. Jpn J Antibiot; 1977 Dec; 30 Suppl():70-84. PubMed ID: 612711 [Abstract] [Full Text] [Related]
13. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties. Ueki M, Ueno K, Miyadoh S, Abe K, Shibata K, Taniguchi M, Oi S. J Antibiot (Tokyo); 1993 Jul; 46(7):1089-94. PubMed ID: 8360104 [Abstract] [Full Text] [Related]
14. Recent developments in the process improvement of production of antitumor anthracycline antibiotics. Oki T. Adv Biotechnol Processes; 1984 Jul; 3():163-96. PubMed ID: 6399842 [No Abstract] [Full Text] [Related]
15. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A. Hoshino T, Sekine Y, Fujiwara A. J Antibiot (Tokyo); 1983 Nov; 36(11):1458-62. PubMed ID: 6581152 [Abstract] [Full Text] [Related]
16. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133. Kim HS, Kim YH, Yoo OJ, Lee JJ. Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322 [Abstract] [Full Text] [Related]
17. Fredericamycin A, a new antitumor antibiotic. I. Production, isolation and physicochemical properties. Pandey RC, Toussaint MW, Stroshane RM, Kalita CC, Aszalos AA, Garretson AL, Wei TT, Byrne KM, Geoghegan RF, White RJ. J Antibiot (Tokyo); 1981 Nov; 34(11):1389-401. PubMed ID: 6798004 [Abstract] [Full Text] [Related]
18. New anthracycline antibiotics, auramycins and sulfurmycins. II. Isolation and characterization of 10 minor components (C approximately G). Hoshino T, Tazoe M, Nomura S, Fujiwara A. J Antibiot (Tokyo); 1982 Oct; 35(10):1271-9. PubMed ID: 7186414 [Abstract] [Full Text] [Related]
19. High performance liquid chromatographic determination of aclacinomycin A and its related compounds. I. Normal phase HPLC for monitoring fermentation and purification processes. Ogasawara T, Goto S, Mori S, Oki T. J Antibiot (Tokyo); 1981 Jan; 34(1):47-51. PubMed ID: 6941957 [Abstract] [Full Text] [Related]
20. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives. Soga K, Furusho H, Mori S, Oki T. J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]